Patrice J Morin

Title: The Innovative Contributions of Patrice J Morin

Introduction

Patrice J Morin is a notable inventor based in Columbia, MD (US), recognized for her significant contributions to cancer research. With a total of two patents, her work focuses on innovative methods for screening potential cancer chemopreventative agents.

Latest Patents

Morin's latest patents include groundbreaking research on screening assays for cancer chemopreventative agents. One patent discusses how nonsteroidal anti-inflammatory drugs can dramatically increase intracellular ceramide, leading to apoptosis. This increase is likely mediated by cyclooxygenase inhibition, which elevates arachidonic acid, stimulating sphingomyelinase to produce ceramide. By contacting members of this pathway with test compounds and observing their effects, a method for screening potential cancer chemopreventative agents is established. Another patent highlights the interaction between .beta.-catenin, Tcf-4, and the APC tumor suppressor protein, which plays a crucial role in preventing cancer. The research reveals that the loss of APC function can lead to constitutive transcription of TCF target genes, a significant event in the early transformation of colonic epithelium.

Career Highlights

Throughout her career, Morin has made substantial contributions to the field of cancer research. Her innovative approaches have paved the way for new methods in cancer prevention and treatment.

Collaborations

Morin has collaborated with esteemed colleagues such as Bert Vogelstein and Kenneth W Kinzler, further enhancing her research impact.

Conclusion

Patrice J Morin's work exemplifies the intersection of innovation and cancer research, showcasing her dedication to advancing the understanding of cancer prevention. Her patents reflect a commitment to developing effective strategies for combating cancer, making her a significant figure in the field.